Market Decision Diagnostic
A board-ready go / no-go recommendation, buyer map, evidence and adoption gaps, and a 90-day decision plan.
For innovators
Enter the market with more than a translation.
For women's-health teams with a live product, credible evidence and an active market, channel or clinical-adoption decision.
Where to begin
Buy the decision before the implementation.
Each offer has a fixed purpose, bounded duration and visible output. The work expands only when the evidence justifies it.
Market-to-Care Blueprint
A market architecture connecting stakeholder evidence, purchasing logic, clinical workflow, cultural adaptation, partners and economics.
Pilot-to-Adoption Programme
A governed implementation programme with adoption measures, specialist delivery and an explicit scale, adapt or stop decision.
Strategic Governance Retainer
Ongoing senior decision support after a completed engagement, with an executive cadence and focused partner navigation.
Scope and investment. Each engagement is scoped against the specific decision, market and evidence base, so fees are confirmed in writing after a short qualification conversation rather than published as a list price. A capability overview covering method, deliverables and typical investment ranges is available on request.
The Market-to-Care method
Five decisions. One coherent route.
The method stays consistent; the clinical, market and cultural expertise is configured for the problem.
Frame the decision
Define the live market decision, success threshold, constraints and evidence that could change the answer.
Test the system
Examine evidence, buyers, care pathways, workflows, partners and cultural context as one connected system.
Design the route
Create a sequenced plan with owners, decision gates, implementation economics and a measurable pilot path.
Activate carefully
Configure the right specialist support while keeping scope, quality, evidence and decisions visible.
Decide and compound
End with a clear scale, adapt or stop decision and add the learning to Miso's reusable method.
Community trial
What a clinical trial cannot tell you.
A trial tells you whether something works when people are watched, reminded and often paid. It does not tell you whether anyone reaches for it on a bad week, how they explain it to a friend, or which part they quietly stop doing by day nine.
Miso runs continuous health cohorts — screened, engaged women aged thirty to fifty-five, already tracking how they sleep, move and feel. Putting a product into that setting is a community trial: the same kind of user, in her own life, where the reason something is or is not used can be observed rather than inferred. That gap is usually what separates a good trial result from a disappointing launch.
The first test
Do you have a live market decision?
Share the solution, target market and decision timing. Miso will respond with fit and the smallest sensible starting point.
Start the conversation